• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晶体微观结构对聚(ε-己内酯)微球药物释放行为的影响

Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres.

作者信息

Jeong Jong-Cheol, Lee Jaeyoung, Cho Kilwon

机构信息

Department of Chemical Engineering, School of Environmental Engineering, Polymer Research Institute, Pohang University of Science and Technology, Pohang 790-784, South Korea.

出版信息

J Control Release. 2003 Oct 30;92(3):249-58. doi: 10.1016/s0168-3659(03)00367-5.

DOI:10.1016/s0168-3659(03)00367-5
PMID:14568406
Abstract

This study investigates the release behavior of papaverine from poly(epsilon-caprolactone) (PCL) microparticles prepared by the oil/water solvent evaporation method. Microparticles were characterized in terms of crystalline morphology, size, drug loading, and encapsulation efficiency by using differential scanning calorimetry (DSC), small angle X-ray scattering (SAXS), scanning electron microscopy (SEM), and UV spectrometry. The release behavior of papaverine was governed by the microstructure of PCL microparticles, suggesting that the environment for diffusion changes according to processing conditions such as polymer solution concentration, thermal history, and polymer molecular weight. As the PCL solution concentration increased, the drug release behavior showed a more sustained pattern. This result indicates that the size of the PCL microparticles is a determining factor for drug release. And when higher PCL molecular weight is used for preparation of microparticles, it led to a rapid release. Furthermore, a more delayed pattern of drug release profile was obtained in the sample prepared with higher thermal treatment. These results suggest that the crystalline microstructure of PCL microparticles plays an important role in its drug release behavior.

摘要

本研究考察了通过油/水溶剂蒸发法制备的聚(ε-己内酯)(PCL)微粒中罂粟碱的释放行为。通过差示扫描量热法(DSC)、小角X射线散射(SAXS)、扫描电子显微镜(SEM)和紫外光谱法对微粒的晶体形态、尺寸、载药量和包封率进行了表征。罂粟碱的释放行为受PCL微粒微观结构的控制,这表明扩散环境会根据诸如聚合物溶液浓度、热历史和聚合物分子量等加工条件而变化。随着PCL溶液浓度的增加,药物释放行为呈现出更持久的模式。该结果表明PCL微粒的尺寸是药物释放的一个决定性因素。并且当使用更高分子量的PCL制备微粒时,会导致快速释放。此外,在经过更高热处理制备的样品中获得了更延迟的药物释放曲线模式。这些结果表明PCL微粒的晶体微观结构在其药物释放行为中起重要作用。

相似文献

1
Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres.晶体微观结构对聚(ε-己内酯)微球药物释放行为的影响
J Control Release. 2003 Oct 30;92(3):249-58. doi: 10.1016/s0168-3659(03)00367-5.
2
The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug.含有亲脂性药物和亲水性药物的聚(ε-己内酯)微粒的制备与评价
J Control Release. 2000 Apr 3;65(3):429-38. doi: 10.1016/s0168-3659(99)00253-9.
3
Influence of polymer blends on the characterization of gliclazide--encapsulated into poly (ε-caprolactone) microparticles.聚合物共混物对格列齐特-聚己内酯微球包封特性的影响。
Drug Dev Ind Pharm. 2013 Feb;39(2):352-62. doi: 10.3109/03639045.2012.681383. Epub 2012 Apr 27.
4
Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system.可生物降解的聚(ε-己内酯)-聚(乙二醇)嵌段共聚物:表征及其作为控释系统药物载体的应用
Biomaterials. 2003 Sep;24(20):3563-70. doi: 10.1016/s0142-9612(03)00207-2.
5
Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(epsilon-caprolactone) and their copolymers.基于聚丙交酯、聚己内酯及其共聚物的布洛芬微球的制备、表征及体外释放性能
J Microencapsul. 2005 Feb;22(1):25-36. doi: 10.1080/02652040400026350.
6
Microparticles prepared with poly(hydroxybutyrate-co-hydroxyvalerate) and poly(epsilon-caprolactone) blends to control the release of a drug model.用聚(3-羟基丁酸酯-共-3-羟基戊酸酯)和聚己内酯共混物制备的微粒用于控制药物模型的释放。
J Microencapsul. 2007 Mar;24(2):175-86. doi: 10.1080/02652040701233556.
7
Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.使用聚乙二醇-聚己内酯两亲性嵌段共聚物作为表面活性剂对阿糖胞苷进行微囊化。
Drug Dev Ind Pharm. 2010 Apr;36(4):456-69. doi: 10.3109/03639040903261989.
8
Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.用于伊维菌素递送的可生物降解微粒设计的初步研究:配方参数的设定
Drug Dev Ind Pharm. 2015;41(7):1182-92. doi: 10.3109/03639045.2014.935395. Epub 2014 Jul 4.
9
Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics.采用复乳(W/O/W)溶剂蒸发技术制备的含盐酸左布诺洛尔的聚(ε-己内酯)微粒:某些制剂参数对微粒特性的影响。
J Microencapsul. 2009 Feb;26(1):63-74. doi: 10.1080/02652040802141039.
10
Disodium norcantharidate loaded poly(epsilon-caprolactone) microspheres I. Preparation and evaluation.去甲斑蝥酸钠聚(ε-己内酯)微球 I. 制备与评价
Int J Pharm. 2008 Feb 28;350(1-2):130-7. doi: 10.1016/j.ijpharm.2007.08.030. Epub 2007 Aug 25.

引用本文的文献

1
Fabrication and evaluation of 3D printed PLGA/nHA/GO scaffold for bone tissue engineering.用于骨组织工程的3D打印PLGA/nHA/GO支架的制备与评价
Sci Rep. 2025 Apr 11;15(1):12446. doi: 10.1038/s41598-025-96099-z.
2
Emerging Trends in Snake Venom-Loaded Nanobiosystems for Advanced Medical Applications: A Comprehensive Overview.用于先进医学应用的载蛇毒纳米生物系统的新兴趋势:全面概述
Pharmaceutics. 2025 Feb 6;17(2):204. doi: 10.3390/pharmaceutics17020204.
3
Investigating How All-Trans Retinoic Acid Polycaprolactone (atRA-PCL) Microparticles Alter the Material Properties of 3D Printed Fibrin Constructs.
研究全反式维甲酸聚己内酯(atRA-PCL)微粒如何改变3D打印纤维蛋白构建体的材料特性。
Macromol Biosci. 2025 May;25(5):e2400464. doi: 10.1002/mabi.202400464. Epub 2025 Jan 21.
4
Nanostructured Poly-l-lactide and Polyglycerol Adipate Carriers for the Encapsulation of Usnic Acid: A Promising Approach for Hepatoprotection.用于包封扁枝衣酸的纳米结构聚左旋丙交酯和聚甘油己二酸酯载体:一种有前景的肝脏保护方法。
Polymers (Basel). 2024 Feb 3;16(3):427. doi: 10.3390/polym16030427.
5
Recent Advances in Nanoparticle Development for Drug Delivery: A Comprehensive Review of Polycaprolactone-Based Multi-Arm Architectures.用于药物递送的纳米颗粒开发的最新进展:基于聚己内酯的多臂结构综合综述
Polymers (Basel). 2023 Apr 10;15(8):1835. doi: 10.3390/polym15081835.
6
Polyglycerol Adipate-Grafted Polycaprolactone Nanoparticles as Carriers for the Antimicrobial Compound Usnic Acid.聚甘油酯接枝聚己内酯纳米粒子作为抗菌化合物长叶松素的载体。
Int J Mol Sci. 2022 Nov 18;23(22):14339. doi: 10.3390/ijms232214339.
7
Reactive Magnetron Plasma Modification of Electrospun PLLA Scaffolds with Incorporated Chloramphenicol for Controlled Drug Release.用于控释药物的含氯霉素的电纺聚乳酸支架的反应性磁控管等离子体改性
Polymers (Basel). 2022 Jan 18;14(3):373. doi: 10.3390/polym14030373.
8
Polyester Polymeric Nanoparticles as Platforms in the Development of Novel Nanomedicines for Cancer Treatment.聚酯聚合物纳米颗粒作为新型癌症治疗纳米药物开发的平台
Cancers (Basel). 2021 Jul 6;13(14):3387. doi: 10.3390/cancers13143387.
9
Fabrication of tri-layered electrospun polycaprolactone mats with improved sustained drug release profile.制备具有改善的持续药物释放特性的三层电纺聚己内酯垫。
Sci Rep. 2020 Oct 23;10(1):18179. doi: 10.1038/s41598-020-74885-1.
10
A Novel pH-Tunable Secondary Conformation Containing Mixed Micellar System in Anticancer Treatment.一种用于抗癌治疗的含新型pH可调二级构象混合胶束系统。
Cancers (Basel). 2020 Feb 21;12(2):503. doi: 10.3390/cancers12020503.